Biocon Q3 net profit up 9% at Rs 93 crore
USP develops standards for the identity, strength, quality and purity of medicines, medicinal ingredients, botanical medicinal ingredients, dietary supplements, food ingredients and compounded medicines manufactured, prepared, distributed and consumed worldwide.
"She will be guiding USP policies, finances and strategic direction as well as will serve as a member of USP Biologics Advisory Group," the company said.
Stocks More on Biocon
Company INFO More on Biocon
Be the first to comment.